Towards open science : promoting innovation in pharmaceutical research and development and access to affordable medications both in Canada and abroad / Bill Casey, chair. : XC62-1/1-421-20E-PDF
"In Canada and around the world, there is rising concern that innovative drugs produced by pharmaceutical companies are no longer affordable and are placing increasing strain on health care budgets. Policy makers have begun to examine ways that public funding for pharmaceutical research and development could address this issue"--Summary, page 1.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.865221&sl=1
Ministère/Organisme | Canada. Parliament. House of Commons. Standing Committee on Health. |
---|---|
Titre | Towards open science : promoting innovation in pharmaceutical research and development and access to affordable medications both in Canada and abroad / Bill Casey, chair. |
Variante du titre | Promoting innovation in pharmaceutical research and development and access to affordable medications both in Canada and abroad |
Titre de la série | Report of the Standing Committee on Health ; 20th report, 42nd Parliament, 1st session |
Type de publication | Série - Voir l'enregistrement principal |
Langue | [Anglais] |
Autres langues publiées | [Français] |
Format | Électronique |
Document électronique | |
Note(s) | "November 2018." Issued also in HTML format. Original published on: 2018/11/26; published on: 2018/11/28; published on: 2019/05/09. Issued also in French under title: Vers la science ouverte : promouvoir l'innovation en recherche et en développement pharmaceutique, et l'accès à des médicaments abordables au Canada et à l'étranger. Includes bibliographical references. |
Information sur la publication | [Ottawa] : House of Commons, 2018. |
Auteur / Contributeur | Casey, Bill, 1945- |
Description | 1 online resource (viii, 27 pages) : graphs. |
Numéro de catalogue |
|
Descripteurs | Pharmaceutical industry Research and development Drugs |